IL24 and prostate carcinoma: Cytokine mda-7/IL-24 has been extensively investigated for selective antitumor effect on prostate cancer [46], lung cancer [47], ovarian cancer [48], breast carcinoma [49], colorectal cancer [50], and glioma [51].